Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Clinical trial NCT04291105 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04291105
Sponsor: Vyriad, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Head and Neck Squamous Cell Carcinoma Colo-rectal Cancer

Start date: 2020-04-24
Primary completion: 2026-10-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.